June 28, 2022

Now Enrolling: The EA9213 clinical trial is testing a new treatment for patients with T-cell acute lymphoblastic leukemia

This trial is for patients who have leukemia cells still in the blood or bone marrow after initial treatment
March 24, 2022

Trial Results: ECOG-ACRIN research round-up – Spring 2022

Summaries of recently reported ECOG-ACRIN research results
December 15, 2021

Trial Results: Blood cancers are the focus of recent ECOG-ACRIN research

Summaries of leukemia, lymphoma, and myeloma research results
October 14, 2019

Trial Results: With E1912, there is a new standard of care for the initial treatment of patients with chronic lymphocytic leukemia

The combination of ibrutinib plus rituximab was superior to standard treatment for CLL patients age 70 and younger.